CDSCO Panel Grants Roche's Protocol Amendment Proposal For Anti-cancer Drug Giredestrant Dr. Divya Colin24 Feb 2024 5:15 PM ISTNew Delhi: The Subject Expert Committee (SEC) functional under the Central Drug Standard Control Organisation (CDSCO) has approved the protocol...
Biocon receives over Rs 3 crore penalty over GST related issues Ruchika Sharma24 Feb 2024 4:30 PM ISTNew Delhi: Biocon Ltd has said it has been imposed a penalty of over Rs 3 crore over GST-related issues. The company has received an order of...
Orchid Pharma bags USFDA nod for Enmetazobactam Ruchika Sharma24 Feb 2024 1:30 PM ISTThis New Drug Approval allows the use of Exblifep (Cefepime and Enmetazobactam) as an injection for the treatment of patients 18 years and older with...
Morepen Labs receives board approval to raise up to Rs 350 crore Ruchika Sharma24 Feb 2024 12:30 PM ISTNew Delhi: Morepen Laboratories on Thursday said its board has approved to raise up to Rs 350 crore via issue of securities.The company's board...
USFDA completes inspections at Suven Pharma facilities with no form 483 Ruchika Sharma24 Feb 2024 11:45 AM ISTHyderabad: Suven Pharma has announced that the US Food & Drug Administration (US FDA) has completed the inspections at the Company's...
Dupixent application accepted for priority review by USFDA for COPD with type 2 inflammation Ruchika Sharma23 Feb 2024 4:30 PM ISTParis: Sanofi has announced that the U.S. Food and Drug Administration (FDA) has accepted for Priority Review the supplemental Biologics License...
Bayer begins Phase II study with anti-alpha2 antiplasmin antibody in patients with deep vein thrombosis Ruchika Sharma23 Feb 2024 2:30 PM ISTBerlin: Bayer has announced the start of a Phase II clinical trial (SIRIUS study) with BAY3018250, an investigational first-in-class anti-alpha2...
Zydus Lifesciences incorporates wholly owned subsidiary company in UAE Ruchika Sharma23 Feb 2024 1:30 PM ISTAhmedabad: Zydus Lifesciences has incorporated a wholly owned subsidiary company in the name of Zydus Lifesciences Global FZE. in Jebel...
AstraZeneca completes acquisition of Gracell Biotechnologies Ruchika Sharma23 Feb 2024 12:30 PM ISTGracell will operate as a wholly owned subsidiary of AstraZeneca, with operations in China and the US.
Novavax settles dispute with Gavi Ruchika Sharma23 Feb 2024 11:30 AM ISTNovavax has agreed to pay back international vaccine group Gavi at least $475 million in cash or vaccines by the end of 2028, settling a dispute over...
Cipla, Dr Reddys and other Indian Pharma companies now in race to develop Wegovy versions Ruchika Sharma22 Feb 2024 2:27 PM IST"Dr Reddy's and Cipla are making a copy of the innovator drug more like a generic version, while Sun is working on its own innovator drug. So, Sun...
USFDA accepts for priority review Bristol Myers Squibb application for Krazati, cetuximab combo for colorectal cancer Ruchika Sharma22 Feb 2024 1:30 PM ISTNew York: Bristol Myers Squibb has announced that the U.S. Food and Drug Administration (FDA) has accepted for priority review the supplemental...
